Medpace Holdings, Inc. (MEDP)

NASDAQ: MEDP · Real-Time Price · USD

618.47

-10.13 (-1.61%)

At close: Oct 16, 2026, 4:00 PM EDT

618.00

-0.47 (-0.08%)

Pre-market: Oct 19, 2026, 7:23 AM EDT

Medpace Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	17,263	15,821	10,326	9,405	6,606	7,822
Market Cap Growth	19.47%	53.21%	9.79%	42.38%	-15.54%	57.08%
Enterprise Value	16,904	15,679	9,821	9,474	6,873	7,567
Last Close Price	618.47	561.65	332.23	306.53	212.41	217.64

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	36.26	35.07	25.54	33.28	26.94	43.12
Forward PE	33.74	33.86	27.33	31.74	27.33	42.23
PS Ratio	6.20	6.25	4.90	4.99	4.53	6.85
PB Ratio	39.79	34.46	12.51	16.83	17.10	8.21
P/TBV Ratio	-	-	80.18	-	-	31.39
P/FCF Ratio	24.43	23.20	18.04	23.71	18.81	33.28
P/OCF Ratio	22.94	22.18	16.96	21.70	17.02	29.70
PEG Ratio	2.64	2.43	1.74	1.24	1.24	13.50

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	6.08	6.20	4.66	5.02	4.71	6.62
EV/EBITDA Ratio	27.66	27.85	20.63	26.09	22.83	34.44
EV/EBIT Ratio	28.97	29.31	21.98	28.13	24.66	38.10
EV/FCF Ratio	23.92	23.00	17.16	23.88	19.57	32.19

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.33	0.30	0.18	0.29	0.54	0.16
Debt / EBITDA Ratio	0.22	0.23	0.29	0.41	0.62	0.59
Debt / FCF Ratio	0.20	0.20	0.26	0.42	0.59	0.63
Net Debt / Equity Ratio	-0.83	-0.78	-0.63	-0.14	0.47	-0.33
Net Debt / EBITDA Ratio	-0.59	-0.64	-1.09	-0.22	0.60	-1.43
Net Debt / FCF Ratio	-0.51	-0.53	-0.91	-0.20	0.51	-1.34
Asset Turnover	1.53	1.24	1.12	1.25	0.97	0.75
Quick Ratio	0.66	0.69	0.90	0.60	0.37	1.16
Current Ratio	0.73	0.74	0.93	0.64	0.42	1.24
Return on Equity (ROE)	162.15%	70.23%	58.42%	59.83%	36.64%	20.68%
Return on Assets (ROA)	20.10%	16.40%	14.87%	13.99%	11.56%	8.14%
Return on Invested Capital (ROIC)	573.33%	219.99%	96.91%	54.35%	40.12%	27.57%
Return on Capital Employed (ROCE)	93.80%	84.70%	44.90%	46.00%	50.80%	18.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.85%	2.85%	3.92%	3.01%	3.71%	2.33%
FCF Yield	4.09%	4.31%	5.54%	4.22%	5.32%	3.00%
Buyback Yield / Dilution	7.24%	7.77%	-0.54%	5.44%	10.68%	0.03%

SEC Filings: 10-K · 10-Q